Mucoepidermoid carcinoma is one ofthe most common of the salivary gland neoplasms. Histologically, it is classif ied as either a low-, intermediate-, or high-grade tumor, and there are significant differences in prognosis among the different grades. Patients with low-grade disease . have an excellent chance of survival. High-grade tumors behave aggre ssively, and they f requently manifest as local recurr ences and distant metastases. We describe a case of a high-grad e mucoepidermoid carcinoma of the parotid gland that had metastasized to the skin, stomach, and liver. The disease culminated in a rapidly fatal bleeding f rom the stomach metastasis. Such a complication is unusual and to our knowledge has not been previously reported. We briefly discuss the clinical fe atures, biologic behavior, and treatment of this tumor.
Introduction
Muco epidermoid carcinoma of the salivary gland was first reported by Stewart et al in 1945. 1 The y described an unusu al salivary gland neopla sm that cont ained epidermoid and mucus-secreting cell s, which were thought to arise from the salivary gland duct s. Mo st cases of mucoepidermoid carcinoma are located in the parotid gland.' Microscopic ally , four types of cell can be identified: mucin-producing, squamous, intermediate, and clear. Tumors are graded according to a three -tiered scoring system, which is based on an evaluation of several morphologic characteri stics : the amount of intracystic component, the type of cell composition , the pattern of invasion, the presence or absence of necrosis, the mitotic count, and the degree of nuclear pleomorphism. 3 The total score establi shes whether the tumor is classified as a low-, interrnediate-, or high-grade carcinoma. A highgrade tumor is characterized by a smaller amount of intracystic component, a higher mitotic count, and the presence of neur al invasion, necrosis, and anaplasia. The histologic grading of mucoepidermoid carcinomas of the major salivary glands correlates well with the clinical, pathologic, and flow cytometric factors that influence prognosis and ove rall survival.' For example, lymph node metastasis is seen in 75% of high-grade tumors, but in only 20% of intermediate-grade tumors.
In this article, we describe a fatal case of a high-grade mucoepidermoid carcinoma of the parotid gland that had metastasized to the skin, stom ach, and liver. We also briefly discu ss the clinical features , biologic behavior, and treatment of this tumor.
Case report
A 58-year-old man was referr ed to us for the management of a painful cheek mass of I month's duration. His medic al history was otherwise unremarkable. Physical examination revealed the presence of an irregular, hard mass with a diameter of 5 em in the left parotid region. The lump was fixed to the underlying tissue , and facial nerve palsy was evident. Blood test results were essentially norm al; one exception was a slightly raised alkaline TO, TSANG , PANG , CHENG , TSE, TSANG Figure 1 . MR1shows a 5-cmleft parotid tumor !arrows) infiltrating the adjacent sternocle idomastoid and digastric muscles. phosphatase level of 125 lUlL (normal: 40 to 100).
Magnetic reson ance imaging (MRI) detected a 5.5 -cm infiltra tive left parotid tumor with an extracapsular spread to the adjacent sternocleidomastoid and digastric musc les (figure I). Left upper cervical lymphadenopathy was also noted. Fine-needle aspiration cyto logy of the parotid mass was inco nclusive. The che st x-ray was normal. Nasoph aryngoscopy ruled out a nasopharyngeal carcinoma (which is relatively common in Southern China) metastatic to an intraparotid lymph node.
In view of the malignant nature of the lesion, left radical parotide ctomy with neck dissection was planned. Intraoperati vely, multip le skin nodules were noted in the cervica l skin flap . Frozen -section ana lysis identified these nodule s as high-grade mucoepidermoid carcinomas. Because of the exten sive neck disease, the patient was inoperable, and chemotherapy was planned.' However, on postoperati ve day 6, the patient developed a distended abdomen and passed a massive amount of melena through the rectum .
An urgent esophagoduodenogastro scopy confirmed the presence of fresh bleeding from the stomach. Emergency laparotomy detected several bleeding tumors in the stomach and numerous depo sits in the liver . Frozen-section analysis of these nodules confirmed the presence of a metastasis (figure 2). After the bleeding sites in the stomach were plicated , the wound was close d. The patient died 2 days later of multiple organ failure . 672 ..
Figure 2. Photom icrograph shows a cellular tumor with a mixture ofmalignant cells-including clear cells, basaloid cells, and polygonal squamous cells (arrow) (original magnification x 20).

Discussion
Mucoepidermoid carcinoma of the parotid gland usually manifests as an asymptomatic swelling. Facial nerve palsy is observed in 17% of patient s with intermediate-or high -grade disease." Fixation or ulceration of the skin occurs in 38% of the se cases."
Most cases of mucoepidermoid carcinoma are treated with surgery. Frequently, the histologic grade of the tumor is not determined until the final resection specimen is exa mined . Therefore, the extent of resection depend s on the aggressiveness of the tumo r as determined by its size and location, as well as the presence or absenc e of regional or dis tant metastasis.
The use of the stage I to IV des ignatio n system for salivary gland mucoepidermoid carc inoma is well established.' Parotidectomy with preservation of the facial nerve is the treatment of choice for stag e I and II disea se. The presence of stage III disease or a local recurrence necessitates sacrificing the facia l nerve and sometimes the overlying skin andlor adjacent masseter muscle . Th e preferred approach to stage IV disease is radic al parotidectomy, radical neck dissecti on, and postoperati ve radiotherapy. Radical neck dissection is recommended for tumor s larger than 4 em in diamet er, irrespective of the clinical staging in the neck ." Electi ve neck dissection has also been suggested for high -grade tumors and larger tumor s becau se of the high rate of occult neck node metastasis.'
The difference in progno sis betw een low-and highgrade disease is striking." For example, 5-year survival rates are 98 and 46 %, respectively." The incidence of distant metastasis has been reported to be 15% in patients with clinical stage III disease." The most common site of distant metastasis is the soft tissue of the skin, followed by
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Safety considerations
• The most frequently reported adverse events associated with the pharmacologic action of a muscarinic agonist (>10% incidence) in clinical trials of cevimeline were: excessive sweating, nausea, rhinitis, and diarrhea. Consult the brief summary of prescribing information for other adverse events SkinandAppendages Disorders: acne, al opecia, burn,derma titi s,contact dermatitis, lichenoid dermatitis, eczema, furuncul osis, hy perkeratosis, lichenplanus,naildiscoloration, nail disorder, onychia,onychomycosis, paronychi a, photosensitivity reaction, rosacea, scieroderma, seborrhea,skindiscoloration, dryski n,skinexfoliation, ski nhypertrophy, skinulceration, urt icar ia, verru ca, bullous eruption, coldclam myski n SpecialSenses Disorders: deafness, decreased hearing, mot ion sickness, parosmia,tasteperversion, blepharitis, cataract, corneal opacity,cornea l ulceration, dipl opia, glaucoma, ant erior chamber eyehemorrhage, keratit is, kerat oconjunct ivitis, mydriasis, myopia, photopsia, retinal deposits, retinal disorder, scleritis, vi treousdetachment, tinni tus Urogen/lal Disorders: epididymitis, prostatic disorder, abnormal sexual functi on,amenorrhea, lemalebreast neoplasm, malignantfemal ebreast neopl asm, femalebreast pain, posi tivecervical smear test, dysmenorrhea, endometrial disorder , mtermenstrual bl eeding, leukorrhea, menorrhagi a, menstrualdisorder, ovarian cyst, ovarian disorder, genital pruritus, uterinehemorrhage,vaginal hemorrhage, atrophic vaginitis, albuminuria, bladderdiscomf ort, increased blood ureã~_~~I gi~c~r; i . r~n~er~~~u:~~a~~c~r:~~, n r~~s ãr~: ĩ , n; f~~~~i~,~~~~~~~'~~;~~~; : ' dab~6f~t l e~~ĩ~~~~~~t 1~~on; s~~~~~, decreased urineflow,pyuria In onesubjectwi th lupus erythema tosus recei vingconcomitant multipl edrugtherapy, a highlyelevated ALT level was notedalterthetourth week ot cevimeiinetherapy. In twoothersubjects receivingcevi melineintheclinical trials, very highAST levels were noted. Thesignificance ot these tindings isunknown. Additional adverseevents (relat ionship unknown) whi ch occurr ed in otherclinicalstudies (patientpopulationdifferent from Sjogren's patients)areasfollows: cholinergic syndrome,bloodpressure fluctuation, car diomegaiy, postural hypotension, aphasia, convul sions,abnormal gait,hyperesthesia, paral ysis, abnormalsexualfunction, enlargedabdomen,change in bowelhabits, gum hyperpl asia, intestinal obstruction,bundle branchblock, increased creatinephosphokinase, electrolyteabnormality, glycosuria, gout, hyperkalemia, hyperproteinemia, increased lactic dehydrogenase(LoH),increasedalkaline phosphatase, failure tothrive, abnormal pl atel et s, aggressive reaction, amnesia, apathy, delirium,deiusion, dementia, illusi on,impotence, neurosis, par anoidreactio n, personalitydi sorder, hyperhemoglobinemia,apnea, atelectasis , yawning, oliguria, Drug Inleraclions: Cevimelineshould beadmi nistered wi th cautionto patients taking betaadrenergicantagonists, because of the possibility of conduction disturbances. Drugs with parasympathomimetic effects admi nistered concurrently wi thcevimeline can beexpect ed to haveadd itive effects. Cevimeline might intertere wit h desirable antimuscarinic effectsofdrugs usedconcomitantly, Drugswhichinhibi t CYP206and CYP3A3J4 also inhibi t themetaboiismof cevi meline. Cevimelineshould beused with cautioninindividualsknown orsuspected to bedefi cient in CYP206 activity, based onprevious experience, as they maybeatahigher risk ofadverseevents. In an in vit rostudy, cytochromeP450 isozymes lA2, 2A6, 2C9, 2C19, 206, 2El , and 3A4 were not inhibited by exposureto cevimeline. C arcinogenesis, Mulagenesis andImpairmenl 01 Fertility: Li fet imecarcinogenicity studieswereconducted in CO-Ĩ I ce andF·344 rats. Astatistically significant increaseintheinci denceofadenoca rcinomas ofthe uteruswasobserved mfemalerat s that received cevi melineat adosageof 100 mg/kg/day (approximately8 times themaximum human :~~~~~; c: ag;af ; ' comparison of AUC data). Noother significant dillerencesin tumor incidencewere observed in Cevimel ineexhibited no evidence of mut agenici ty orclastogenicityinabattery of assays thatincludedan Amestest, an mvrtro chromosomal aberration studyin mammaliancells, amouselymphomastudy in L51 78Yce lls,or amicronucleusassay conducted in vivo inICRmice. Cevimelinedidnot adver seiy affectthereproductivepertormanceor fertility otmale Sprague-DaWley rats when administ eredfor63daysprior to mating andthroughout the per iodof ma tingatdosages up to 45mg/kglday (approximately 5 times the maximum recommendeddose for a60 kg human following normali zation ot thedata onthebasi s otbody surtace area estimates). Femalesthatweretreatedwit h cevimelineat dosag esupto 45 mglkglday from 14daysprior~~;~: n agnl~~9h daysevenof gestationexhibttedastatistically significantly smallernumber otimplantations than did M the lung, liver, and bone." Metastasis to the stomach that results in fatal tumor bleeding is uncommon and to our know ledge has not been prev iously reported in the literature.
In retrospect, a more intensive metastatic wor kup for our patient-with panendoscopy, liver ultrasound, co mputed tom ography of the brain, and whole-body bone scanning-could have changed our treatment approac h from curative to palliati ve.
The clinica l features assoc iated with metastasis or death are adv anced age, tumor size, and preoperative symptoms.' ? Furthermore, a significa nt correlati on has been dem onstr ated bet ween the clinical stage of muco ep idermoid carc inoma and its histologic grading. Stage I tumors are usually of low histologic gra de and are effective ly contro lled by conservati ve surgical procedures. Rad ical operat ions are often ineffecti ve for patie nts with stage III and IV tum ors, most of which are found to be of high histologic grade.' These findin gs strongly suggest that therapeutic deci sion s should not be based solely on histologic grading. For more information 011 the eME program contact:
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